Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits

• Nicholas J. Izzo ,

  * E-mail: nizzo@cogrx.com

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Agnes Staniszewski,

  Affiliation Department of Pathology and Cell Biology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, New York, United States of America

  ⨯
• Lillian To,

  Affiliation Stanford University Medical School Behavioral and Functional Neuroscience Laboratory, Palo Alto, California, United States of America

  ⨯
• Mauro Fa,

  Affiliation Department of Pathology and Cell Biology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, New York, United States of America

  ⨯
• Andrew F. Teich,

  Affiliation Department of Pathology and Cell Biology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, New York, United States of America

  ⨯
• Faisal Saeed,

  Affiliation Department of Pathology and Cell Biology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, New York, United States of America

  ⨯
• Harrison Wostein,

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Thomas Walko III,

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Anisha Vaswani,

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Meghan Wardius,

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Zanobia Syed,

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Jessica Ravenscroft,

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Kelsie Mozzoni,

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Colleen Silky,

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Courtney Rehak,

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Raymond Yurko,

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Patricia Finn,

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Gary Look,

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Gilbert Rishton,

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Hank Safferstein,

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Miles Miller,

  Affiliation Department of Pathology and Neurosurgery, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States of America

  ⨯
• Conrad Johanson,

  Affiliation Department of Pathology and Neurosurgery, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States of America

  ⨯
• Edward Stopa,

  Affiliation Department of Pathology and Neurosurgery, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States of America

  ⨯
• Manfred Windisch,

  Affiliation NeuroScios, GmbH, Graz, Austria

  ⨯
• Birgit Hutter-Paier,

  Affiliation QPS Austria GmbH, Grambach, Austria

  ⨯
• Mehrdad Shamloo,

  Affiliation Stanford University Medical School Behavioral and Functional Neuroscience Laboratory, Palo Alto, California, United States of America

  ⨯
• Ottavio Arancio,

  Affiliation Department of Pathology and Cell Biology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, New York, United States of America

  ⨯
• Harry LeVine III,

  Affiliation Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, United States of America

  ⨯
•  [ ... ],
• Susan M. Catalano

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• [ view all ]
• [ view less ]